Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase - Wikidata - wikimedia - TriplyDB

Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase

Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase

http://www.wikidata.org/entity/Q24310374

about

sameAs

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Arachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevance Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain Development of an HTS assay for EPHX2 phosphatase activity and screening of nontargeted libraries Soluble epoxide hydrolase in atherosclerosis Expression and regulation of soluble epoxide hydrolase in adipose tissue Epoxides and soluble epoxide hydrolase in cardiovascular physiology Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids.The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease.From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase.The cytochrome P450 pathway in angiogenesis and endothelial cell biology.Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Human HAD phosphatases: structure, mechanism, and roles in health and disease.Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase Estrogen-dependent epigenetic regulation of soluble epoxide hydrolase via DNA methylation.Complementary Screening Techniques Yielded Fragments that Inhibit the Phosphatase Activity of Soluble Epoxide Hydrolase

P2860

9aeeecfee2a396fd9a5dd2b29f0bf7cdaec4adbe bbcb0e76acd5309f230aefd46a3c4172674078be ce683b9ba092c119e5b92caf60c6f7429ccbec08 ceb1415702c5178f3da7114e53cb68cc8b5e293a d9021fac56187ff605526c7ee22fc5e9ad4036c9 ff7695c06dea327db248c7ad312f11f5db3d213d

P248

Q24597172-B1E78D76-8A87-4A82-833F-1F122892E967 Q27024958-5190618D-AD3E-4D12-B5EA-A705A4BA11DF Q28383719-D16C0BB9-0808-4B98-825A-A040E01E0711 Q28388993-5B290FBD-E5C0-40FD-A0F4-F059F6E45930 Q28390006-C77416B0-67C4-4B62-AFFE-E484AABF2D34 Q28390217-F89B117A-065A-42FF-83F8-1F534FDE9991 Q28392416-4C1A54E1-7C34-4BF6-842D-B0B7F398D24F Q28393751-3C7CCDCB-E5BF-4CCB-95F4-39DBF59CEAF2 Q28395004-667CFFF7-07A1-4D3F-BE43-A686479E629B Q28395245-30F15EAE-00FB-476C-9836-5C1F51115DA4 Q28396313-531022E6-8F68-4B93-982E-6E791465013F Q33814824-3906A3D7-B238-42DB-9D50-7F98AC6F758D Q34183871-8E6B339A-BCCE-4800-9FC1-2888F9DAB534 Q34332185-B49B9B6C-0566-4F57-AFCB-8DF381724260 Q34675957-0DEC3196-EC3E-434C-AA40-6B7C6DA87731 Q35992841-7D1B228F-61F7-4D0D-ACC0-55385C8384A9 Q37947082-4529B979-0324-4D62-959C-2E34B3910350 Q37960812-BEB35C0E-D6CA-48EB-B7B7-6640F1DDA85C Q38011246-194FEA82-2EE3-4B4E-8387-B1ECB5ACD899 Q38184587-B1DCBCE7-F344-43B7-A5CE-CC360EE622B9 Q38763928-AB7BD338-70ED-447B-9E1E-4004B691CEC5 Q40989424-1D4E746A-FDC2-4EBB-878B-EA39FF25CC11 Q47236811-13541B7C-A38C-4445-8B7B-22D9B68BA2F5 Q57903650-E080C79F-367A-4531-B95E-6293BA98FE64

P2860

Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase

http://www.wikidata.org/entity/Q24310374

description

2008 nî lūn-bûn

@nan

2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@ast

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@en

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@en-gb

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@nl

type

label

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@ast

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@en

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@en-gb

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@nl

prefLabel

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@ast

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@en

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@en-gb

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@nl

P1433

Q24310374-44BD430E-F86D-4DDA-A0A1-7A0ECF6AFDBA

P1476

Q24310374-F2D8E472-7463-4660-AE77-796462DCA1DA

P2093

Q24310374-297C5052-74C0-4D64-84E4-18875C3C4203

Q24310374-36451496-FA1C-452F-B3D1-5CA296F4EEE0

Q24310374-80D086FC-9B50-45F9-BC37-D1984AC83972

Q24310374-855A77B1-F275-4FF0-A3EA-00017F5B0C75

Q24310374-9684675A-62A5-4849-8B4B-E0334AC97165

P2860

Q24310374-031FDE9A-501D-40A1-9088-B830ACCB4D91

Q24310374-08412AF9-6851-41D9-8CFF-65A673D8DD93

Q24310374-0B3A3F52-01DE-4F62-B4E1-07E5E8776A94

Q24310374-0FAFD174-CC7E-4F18-9D08-92A0FEE1E705

Q24310374-1D894902-4E3E-4662-9C51-35C07FC3641F

Q24310374-22813660-1393-4C10-95C8-FA4DD0A49A85

Q24310374-2B281DAE-1EC5-4E7D-BE88-8D4267589F4D

Q24310374-301A687F-5480-4751-AC0B-8F0F9663824D

Q24310374-302FAA0D-6289-46CD-82D6-1292214FAC36

Q24310374-357751A9-0E86-48C3-894E-27E191E2D340

P304

Q24310374-6CFFA5E9-255C-4D5A-8B07-DB26C73CC105

P31

Q24310374-4073BB65-CC41-4A59-BF3D-E3215DEF190B

P356

Q24310374-6CFB4BA2-7B54-4158-95C4-178F1599AC03

P407

Q24310374-BC564658-97EA-4B69-A64F-8302DB200E39

P433

Q24310374-61ADED31-5600-4734-9BE9-298BE3DE0FC8

P478

Q24310374-224C74CA-FDB6-424D-9653-4B3663B07170

P50

Q24310374-88B8FDF7-EE59-43B4-9A3F-B82E8AEDB9A7

Q24310374-F75E8CF6-8194-4D41-BC9B-E7775C2BFD80

P577

Q24310374-E1A6A63B-BCC2-4721-999C-D29454FC881B

P698

Q24310374-064EB5CB-D290-4E20-A348-F49795EA12AD

P921

Q24310374-30993B11-0762-41C7-A2DE-110F01230979

Q24310374-3D02E9C0-467F-4C49-BA10-422E06D27ADF

Q24310374-5B168B16-36A0-49CE-8696-9691DED6E62F

Q24310374-6C3478A8-6CEC-4853-B05C-344D7C93F57F

P932

Q24310374-93CE5C1C-C41A-4E7A-932C-633DC8E5F69B

P356

P1433

Journal of Biological Chemistry

P1476

Opposite regulation of cholest ...... s of soluble epoxide hydrolase

@en

P2093

Ahmed E EnayetAllah

http://www.w3.org/2001/XMLSchema#string

Beibei Luo

http://www.w3.org/2001/XMLSchema#string

David F Grant

http://www.w3.org/2001/XMLSchema#string

Hsing-Ju Tsai

http://www.w3.org/2001/XMLSchema#string

Priyanka Sura

http://www.w3.org/2001/XMLSchema#string

P2860

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase

The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity

Protein quaternary structure and expression levels contribute to peroxisomal-targeting-sequence-1-mediated peroxisomal import of human soluble epoxide hydrolase

Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase

The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism

Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function

Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis

Cytochrome P450 epoxygenases provide a novel mechanism for penile erection

P304

36592-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M806315200

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P50

Bruce D. Hammock

P577

2008-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18974052

http://www.w3.org/2001/XMLSchema#string

P921

regulation of cholesterol metabolic process

Epoxide hydrolase 2

Epoxide hydrolase 2, cytoplasmic

P932

2605982

http://www.w3.org/2001/XMLSchema#string